5-乙基-4-甲基嘧啶 | 100868-34-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 5-乙基-4-甲基嘧啶
• 中文别名: 双环[2.2.1]庚烷-2,3,5,6-四醇，(2-endo，3-exo，5-exo，6-exo)-(9CI)
• 英文名称: 5-ethyl-4-methyl-pyrimidine
• 英文别名: 5-Aethyl-4-methyl-pyrimidin；5-Ethyl-4-methylpyrimidine
• CAS: 100868-34-6
• 化学式: C₇H₁₀N₂
• 分子量: 122.17
• InChiKey: VBYNWDSUFLFBCG-UHFFFAOYSA-N

物化性质

• 熔点：
  270-273 °C
• 沸点：
  194 °C
• 密度：
  0.977±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  9
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2,4-dichloro-5-ethyl-6-methylpyrimidine 在 水 、 锌 作用下， 生成 5-乙基-4-甲基嘧啶
  参考文献：
  名称：

  Byk, Chemische Berichte, 1903, vol. 36, p. 1922

  摘要：

  DOI：

文献信息

• [EN] DIHYDROOROTATE DEHYDROGENASE INHIBITORS<br/>[FR] INHIBITEURS DE DIHYDROOROTATE DÉSHYDROGÉNASE
  申请人：JANSSEN BIOTECH INC

  公开号：WO2020212897A1

  公开（公告）日：2020-10-22

  Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula (I) as follows: wherein R1, R2, R3, R4, X, and Y are defined herein.

  揭示了一种通过调节DHODH来治疗受影响的疾病、紊乱或医疗状况的化合物、组合物和方法。这些化合物由以下式（I）所代表：其中R1、R2、R3、R4、X和Y在此处定义。
• Bicyclic And Tricyclic Derivatives As Thrombin Receptor Antagonists
  申请人：Chackalamannil Samuel

  公开号：US20080090830A1

  公开（公告）日：2008-04-17

  Heterocyclic-substituted tricyclics of the formula or a pharmaceutically acceptable salt or solvate of said compound, isomer or racemic mixture wherein represents an optional double bonds the dotted line is optionally a bond or no bonds resulting in a double bond or a single bond, as permitted by the valency requirement and wherein E, A, G M, Het, B, X, R 3 , R 10 , R 11 , R 32 and R 33 are herein defined and the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer by administering said compounds. Combination therapy with other cardiovascular agents is also claimed.

  具有以下结构的杂环取代的三环化合物，或者该化合物的药用盐或溶剂化合物、异构体或消旋混合物，其中表示一个可选的双键，虚线可以是一个键或无键，从而形成一个双键或一个单键，符合化合价要求，E、A、G、M、Het、B、X、R3、R10、R11、R32和R33在此有定义，其余取代基如规范中所定义，以及含有它们的药物组合物和通过给予该化合物治疗与血栓形成、动脉粥样硬化、再狭窄、高血压、心绞痛、心律失常、心力衰竭和癌症相关的疾病的方法。还声称与其他心血管药物的联合疗法。
• CHROMAN DERIVATIVES AS TRPM8 INHIBITORS
  申请人：AMGEN INC.

  公开号：US20140045855A1

  公开（公告）日：2014-02-13

  Chroman compounds and derivatives of Formula I are useful inhibitors of TRPM8. Such compounds are useful in treating a number of TRPM8 mediated disorders and conditions and may be used to prepare medicaments and pharmaceutical compositions useful for treating such disorders and conditions. Examples of such disorders include, but are not limited to, migraines and neuropathic pain. Compounds of Formula I have the following structure: where the definitions of the variables are provided herein.

  Formula I的Chroman化合物和衍生物是TRPM8的有用抑制剂。这些化合物在治疗多种由TRPM8介导的疾病和症状方面具有用途，并可用于制备治疗这些疾病和症状的药物和药物组合物。这些疾病的例子包括，但不限于，偏头痛和神经病性疼痛。Formula I的化合物具有以下结构：变量的定义在此提供。
• Novel ring transformation of nitropyrimidinone; synthetic equivalent of α-nitroformylacetic acid
  作者：Nagatoshi Nishiwaki、Hui-Ping Wang、Kengo Matsuo、Yasuo Tohda、Masahiro Ariga

  DOI：10.1039/a704354f

  日期：——

  3-Methyl-5-nitropyrimidin-4(3H)-one reacts with ketones in the presence of ammonium salts to afford disubstituted pyrimidines and disubstituted 3-nitro-2-pyridones in a novel ring transformation reaction; nitropyrimidinone behaves as an activated diformylamine in the former case, and as a synthetic equivalent of α-nitroformylacetic acid in the latter case.

  3-甲基-5-硝基嘧啶-4(3H)-酮与酮在铵盐存在下发生反应，生成二取代的嘧啶和二取代的 3-硝基-2-吡啶酮，这是一种新颖的环转化反应；硝基嘧啶酮在前一种情况下表现为活化的二甲胺，而在后一种情况下则表现为δ-硝基甲酰乙酸的合成等效物。
• ISOTHIAZOLE AND PYRAZOLE DERIVATIVES AS FUNGICIDES
  申请人：Ackermann Peter

  公开号：US20110224241A1

  公开（公告）日：2011-09-15

  The present invention relates to compounds of Formula (I) wherein R 1 , R 2 , R 3 or R 4 are as defined in claim 1 or a salt or N-oxide thereof and their use in methods for the control and/or prevention of fungal infection, particularly in plants. The compounds claimed are isothiazole and pyrazole derivatives.

  本发明涉及公式（I）的化合物，其中R1，R2，R3或R4如权利要求1所定义，或其盐或N-氧化物，以及它们在控制和/或预防真菌感染的方法中的使用，特别是在植物中。所要求的化合物是异噻唑和吡唑衍生物。